Journal of Genetic Engineering and Biotechnology

Table 2 Antibacterial activity of the Myco-biosynthesized AgNPs using four marine fungal extracts against tested pathogenic bacteria

From: Mycosynthesis of silver nanoparticles using marine fungi and their antimicrobial activity against pathogenic microorganisms

Antibacterial activity (mm)
	E. faecalis	E. coli	K. pneumoniae	MRSA	P. vulgaris	S. typhi	S. hominis	S. epidermidis
Aspergillus terreus
2 mM	Null	Null	Null	Null	Null	Null	Null	Null
5 mM	Null	Null	Null	Null	18 ± 2^c	11 ± 1^f	12 ± 2^d	Null
8 mM	Null	Null	Null	Null	15 ± 2^d	14 ± 1^de	14 ± 2^d	Null
Penicillium simplicissmum
2 mM	11 ± 0^b	Null	Null	Null	23 ± 1^a	17 ± 1^c	24 ± 1^a	Null
5 mM	12 ± 1^ab	13 ± 0^b	Null	Null	15 ± 3^c	22 ± 2^b	20 ± 1^b	13 ± 2^ab
8 mM	10 ± 2^b	13 ± 2^b	Null	Null	13 ± 3^abc	21 ± 2^b	22 ± 1^abc	13 ± 2^ab
Aspergillus oryzae
2 mM	10 ± 1^b	11 ± 0^c	Null	Null	21 ± 1^ab	15 ± 2^cd	23 ± 1^ab	10 ± 1^d
5 mM	12 ± 0^ab	12 ± 1^bc	11 ± 2^a	Null	20 ± 1^bc	22 ± 1^b	21 ± 2^bc	13 ± 0^ab
8 mM	11 ± 2^b	Null	10 ± 0^b	Null	18 ± 1^c	21 ± 2^b	23 ± 2^ab	14 ± 0^a
Aspergillus japonicus
2 mM	12 ± 2^ab	11 ± 2^c	Null	Null	15 ± 2^d	12 ± 2^ef	24 ± 1^a	11 ± 1^cd
5 mM	14 ± 1^a	15 ± 2^a	Null	Null	23 ± 1^a	23 ± 1^ab	22 ± 1^abc	12 ± 2^bc
8 mM	12 ± 2^ab	13 ± 1^b	Null	Null	23 ± 0^a	25 ± 0^a	23 ± 0^ab	13 ± 0^ab

MRSA Methicillin Resistance Staphylococcus aureus, Null No activity. Values are the average of triplicate analyses ± standard deviation. Superscript letters are significantly different at P < 0.05 using Tukey’s HSD (honest significant difference) post hoc test

Back to article page